Clinical Trial Update: A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring tislelizumab combined with bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical cancer; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN